Immuron (IMRN) Invested Capital (2016 - 2025)
Immuron (IMRN) posted quarterly Invested Capital of $1.2 million for Q2 2025, down 28.39% year-on-year from $1.6 million in Q2 2024, and down 28.39% on a QoQ basis from $1.6 million in Q2 2024.
Immuron (IMRN) Invested Capital (2016 - 2025) Analysis & Trends
Immuron (IMRN) has reported Invested Capital for 10 consecutive years, with $1.2 million the latest figure, recorded in Q2 2025.
- Quarterly Invested Capital fell 28.39% year-over-year to $1.2 million in Q2 2025, while the trailing twelve-month figure through Sep 2025 was $1.2 million (down 28.39% YoY) and the FY2025 annual result came in at $1.2 million, down 28.39% from the prior year.
- Invested Capital declined to $1.2 million in Q2 2025 per IMRN's latest filing, from $1.6 million in the prior quarter.
- Over the last five years, Invested Capital for IMRN reached as high as $1.6 million in Q2 2024 and fell as low as $108060.8 in Q2 2021.
- A 5-year average of $856084.8 and a median of $697633.5 in 2023 frame the typical range for Invested Capital.
- Annual changes were most pronounced in 2021 — Invested Capital tumbled 35.47% — and 2022, when it surged 526.6%.
- Year by year, Invested Capital stood at $108060.8 in 2021, then soared by 526.6% to $677104.9 in 2022, then rose by 3.03% to $697633.5 in 2023, then surged by 133.67% to $1.6 million in 2024, then dropped by 28.39% to $1.2 million in 2025.
- According to Business Quant data, Invested Capital over the past three periods registered $1.2 million, $1.6 million, and $697633.5 for Q2 2025, Q2 2024, and Q2 2023 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Invested Cap. (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | 110.96 Mn |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 116.14 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | - |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Immuron | 270.20 Mn | 258.54 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2025 | 1.17 Mn |
| Jun 30, 2024 | 1.63 Mn |
| Jun 30, 2023 | 697,633.45 |
| Jun 30, 2022 | 677,104.91 |
| Jun 30, 2021 | 108,060.85 |
| Jun 30, 2020 | 167,463.53 |
| Dec 31, 2019 | 98,120.00 |
| Jun 30, 2019 | 771,140.14 |
| Jun 30, 2018 | 486,819.03 |
| Dec 31, 2017 | 159,606.78 |
| Sep 28, 2017 | 159,606.78 |
| Aug 31, 2017 | 226,000.00 |
| Jun 30, 2017 | 936,850.82 |
| Dec 31, 2016 | 796,704.06 |